Discover 1,437 paid clinical trials in New Braunfels, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,437
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
for
Breast Cancer
Location: San Antonio TX, Austin TX, Waco TX, Corpus Christi TX,
Sponsor: Agendia
Sex: All
Age: 18+
Code: NCT03053193
Recruiting
New
Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02)
for
Non-Small Cell Lung Cancer
Location: San Antonio TX, Beaumont TX, Palm Bay FL, Winchester VA
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07680790
Phase 3, Recruiting
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: San Antonio TX, Austin TX, Fort Worth TX, Tyler TX,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06136559
Phase 3, Recruiting
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
for
Carcinoma, Non-Small-Cell Lung
Location: San Antonio TX, Austin TX, Houston TX, Spring TX,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06667076
Phase 2, Recruiting
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
for
Non-Small Cell Lung Cancer (NSCLC)
Location: San Antonio TX, Houston TX, Galveston TX, Daphne AL,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07361510
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
for
Carcinoma, Non-Small-Cell Lung
Location: San Antonio TX, Laredo TX, Galveston TX, Dallas TX,
Sponsor: Mirati Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT06875310
Phase 3, Recruiting
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
for
Endometrial Cancer, Recurrent or Progressive Endometrial Cancer
Location: San Antonio TX, Austin TX, Waco TX, Fort Worth TX,
Sponsor: Genmab
Sex: Female
Age: 18+
Code: NCT07166094
Phase 3, Recruiting
New
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Two Formulations of ASC36 Injection in Participants With Obesity or Overweight
for
Chronic Weight Management
Location: San Antonio TX, Salt Lake City UT
Sponsor: Ascletis Pharma (China) Co., Limited
Sex: All
Age: 18 - 65
Code: NCT07893093
Phase 1, Recruiting
First Time in Human Study of Long Acting VH4524184 Formulations
for
HIV Infections
Location: San Antonio TX, Lenexa KS, Salt Lake City UT
Sponsor: ViiV Healthcare
Sex: All
Age: 18 - 55
Code: NCT06310551
Phase 1, Recruiting
Humidity in Incubators for Tiny Infants
for
Extremely Premature Infant
Location: San Antonio TX, Houston TX, Birmingham AL, Columbus OH,
Sponsor: The University of Texas Health Science Center, Houston
Sex: All
Age: 0
Code: NCT06399861
Recruiting
Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset
Location: San Antonio TX, Houston TX, Fort Worth TX, Mobile AL,
Sponsor: The University of Texas Health Science Center, Houston
Sex: All
Age: 0 - 1
Code: NCT05685745
Recruiting
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
for
Secondary Progressive Multiple Sclerosis
Location: San Antonio TX, Sherman TX, Oklahoma City OK,
Sponsor: Zenas BioPharma (USA), LLC
Sex: All
Age: 18 - 60
Code: NCT07299019
Phase 3, Recruiting
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
for
Multiple Sclerosis (MS) Primary Progressive
Location: San Antonio TX, Sherman TX, Cordova TN, Roeland Park KS,
Sponsor: Zenas BioPharma (USA), LLC
Sex: All
Age: 18 - 60
Code: NCT07067463
Phase 3, Recruiting
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
for
High Risk Cardiovascular Disease, Hypertension,
Location: San Antonio TX, Austin TX, Waco TX, Katy TX,
Sponsor: Alnylam Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07181109
Phase 3, Recruiting
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
for
Chronic Obstructive Pulmonary Disease (COPD)
Location: San Antonio TX, Boerne TX, Houston TX, Mesquite TX,
Sponsor: AstraZeneca
Sex: All
Age: 40 - 70+
Code: NCT06878261
Phase 3, Recruiting
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
for
Migraine
Location: San Antonio TX, Houston TX, Tomball TX, Dallas TX,
Sponsor: Pfizer
Sex: All
Age: 6 - 17
Code: NCT05156398
Phase 3, Recruiting
Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adolescents With Chronic Rhinosinusitis Without Nasal Polyps
for
Chronic Rhinosinusitis Without Nasal Polyps
Location: San Antonio TX, Austin TX, Oklahoma City OK, Tulsa OK,
Sponsor: Optinose US Inc.
Sex: All
Age: 12 - 17
Code: NCT06850805
Phase 3, Recruiting
New
Phase 2/3 Efficacy and Safety of PP405 in Adult Males
for
Androgenetic Alopecia
Location: San Antonio TX, Houston TX, Baton Rouge LA,
Sponsor: Pelage Pharmaceuticals, Inc.
Sex: Male
Age: 18 - 55
Code: NCT07819435
Phase 2, Phase 3, Recruiting
New
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
for
Healthy Volunteer, Atopic Dermatitis
Location: San Antonio TX, North Little Rock AR, Birmingham AL,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18 - 65
Code: NCT07527923
Phase 1, Recruiting
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
for
Cutaneous Squamous Cell Carcinoma (CSCC)
Location: San Antonio TX, Austin TX, Cedar Park TX, Houston TX,